Dr. Richard T. Silver MD
Oncologist | Medical Oncology
520 E 70th St New York NY, 10021About
Dr. Silver is Professor of Medicine and Director of the Leukemia and Myleoproliferative Center at New York Presbyterian-Weill Cornell Medical Center. He is also Attending Physician of New York Presbyterian ...
Education and Training
Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University 1953
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
- Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer.
- Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.
- Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
- Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
- Letter: Acute hemolytic episodes 37 years apart.
- Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571.
- The bone marrow in polycythemia vera.
- Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208).
- Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia.
- Treatment of polycythemia vera with recombinant interferon.
- Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia.
- Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.
- Imatinib mesylate (Gleevec(TM)) reduces phlebotomy requirements in polycythemia vera.
- A hope for the future.
Dr. Richard T. Silver MD's Practice location
New York, NY 10021Get Direction
Dr. Richard T. Silver MD's reviews
Write ReviewPatient Experience with Dr. Silver
Recommended Articles
- Ovarian Cancer: Is it Asymptomatic in the Early Stages?
Only three percent of women in the world who are diagnosed with some form of cancer have ovarian cancer. This type of cancer has the highest percentage of deaths in the female population. Every cancer starts when the growth of cells becomes abnormal and out of control. Ovarian cancer begins in the...
- Is Ovarian Cancer Terminal?
Let’s answer the question first: It depends on the stage of the disease. There are four stages of ovarian cancer, and the third and fourth are the most dangerous. The bad thing is that most cases of ovarian cancer are diagnosed in the later stages of the disease, when little can be done to save...
- What to Avoid if You Have Leukemia
Leukemia, known as the cancer of the blood, can progress either acutely, which the is rapid and sudden onset of the disease, or chronically, which is a slow manifestation of symptoms over a period of time. There are several complications of leukemia that may arise which can hinder the patient’s...
- Is Leukemia Hereditary?
Leukemia is a type of cancer that affects a person's blood cells, bone marrow, and lymphatic system. The symptoms associated with leukemia arise because of an increased level of immature or undeveloped white blood cells, also called leukocytes. This abnormality is caused by a mutation in the...
- What Do Doctors Check in Prostate Cancer?
When we talk about prostate cancer, we are referring to a condition that affects the prostate gland. The condition is only found in men. The simple reason is that only men have the prostate gland. The prostate gland is located beneath a man's bladder and around the urethra. The primary function of...
- Chemotherapy for Multiple Sclerosis
For those who suffer from multiple sclerosis, there are a lot of treatments available in managing the symptoms. However, there is no complete cure for this disease. The choice of multiple medications depends on person-to-person since every person’s body responds differently to each treatment....
Nearby Providers
- Dr. Maria Theodoulou MD1275 York Ave New York NY 10021
- Dr. Richard Carvajal M.D.1275 York Ave New York NY 10021
- Dr. Mark Frattini MD1275 York Ave New York NY 10021
- Dr. Craig Moskowitz MD1275 York Ave New York NY 10021
- Dr. Andrew Zalenetz MD1275 York Ave New York NY 10021
- Dr. Emil Lou M.D., PH.D1275 York Avenue New York NY 10021